⚖️ Files federal trademark or copyright suits

Novo Nordisk A/S

Trademark enforcement profile · on record 1991–2026

Novo Nordisk A/S has filed federal trademark or copyright enforcement actions. On record (1991–2026): 82 federal trademark or copyright lawsuits; 16 oppositions and cancellation petitions at the USPTO Trademark Trial and Appeal Board (prevailed in 71% of merits decisions).

Data summary based on public records (USPTO TTAB proceedings and PACER/CourtListener federal court dockets). Figures reflect filings on record, not a characterization of the merits or good faith of any individual action. Not legal advice.

Before you list

Selling anything that might resemble their marks?

Check your design against Novo Nordisk A/S's registered marks — and 13M+ others — before you list.

Check your design free

Free trial · no card · 3 checks that never expire

Federal court filings

0
Schedule-A cases
naming online sellers as defendants
82
Federal trademark cases
nature-of-suit 840
0
Federal copyright cases
nature-of-suit 820

At the Trademark Trial and Appeal Board (TTAB)

13
Oppositions
under 15 U.S.C. §1063
3
Cancellation petitions
under 15 U.S.C. §1064
10
Prevailed
on the merits, by default, or by abandonment
4
Did not prevail
adverse ruling on the merits
2
Settled / withdrawn
ended without a Board ruling on the merits

Prevailed in 71% of proceedings the Board actually decided on the merits (settled and withdrawn proceedings excluded from this calculation).

Designs Novo Nordisk A/S has opposed

Real trademark applications Novo Nordisk A/S challenged at the USPTO — the kind of design that draws an opposition. If your artwork looks like one of these, expect pushback. Each links to its USPTO docket.

Source: USPTO Trademark Trial and Appeal Board records. “Prevailed” means Novo Nordisk A/S got the outcome it sought; settled/withdrawn cases ended without a Board ruling on the merits. Images from public USPTO records.

Marks Novo Nordisk A/S has asserted in proceedings

OZEMPIC
OZEMPIC
asserted in 2 proceedings
WEGOVY
WEGOVY
asserted in 2 proceedings
MarkSerialProceedings
OZEMPICtext791594316
WEGOVYtext793033932
PRANDINtext752720352
INNOLETtext755140872
OZEMPIC794148422
WEGOVY793249132
NASALINtext741429181
SAXENDAtext791416281
CELLUSOFTtext740753151
RHEOZYMEtext754143631

From public USPTO records. A mark is listed when it appears as a senior asserted mark in TTAB or federal-court proceedings on file. Serial links open the USPTO TSDR record.

Selling a design that may resemble Novo Nordisk A/S’s registered marks?

Run a visual similarity check against Novo Nordisk A/S’s registered marks — and 13M+ other USPTO trademark images — before you list. Takes about 10 seconds.

Run a free visual check

FAQ

Data sources: publicly published USPTO Trademark Trial and Appeal Board proceedings (1951–2026, with possible gaps before electronic filing) and U.S. federal court dockets (PACER/CourtListener, nature-of-suit codes 840 and 820). Figures reflect filings on record and do not characterize the merits, validity, or legitimacy of any individual action by Novo Nordisk A/S. Trademark holders have legal rights — and in some doctrines, an obligation — to enforce registered marks. This page does not provide legal advice; consult licensed counsel for case-specific questions. See the full leaderboard.